Navigation Links
New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
Date:10/15/2007

ooking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development, manufacturing and commercialization; the impact of competitive products, including, but not limited to the impact of those on Shire's Attention Deficit and Hyperactivity Disorder ("ADHD") franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine) extended release (ADHD); Shire's ability to secure new products for commercialization and/or development; Shire's ability to benefit from its acquisition of New River Pharmaceuticals, Inc.; the successful development of JUVISTA(R) (human TGFbeta3) and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, particularly Shire plc's Annual Report on Form 10-K for the year ended December 31, 2006.

LIALDA(TM) is a trademark of Shire LLC.

MMX(R) is a registered trademark owned by Cosmo Technologies Ltd, Ireland, a wholly-owned subsidiary of Cosmo Pharmaceuticals SpA.


'/>"/>
SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
7. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
8. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
9. 8-Year Long-term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission with Bexxar
10. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
11. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... its orally ingestible insulin capsule on type 1 diabetic ... the ADA 75 th Scientific Sessions on June ... poster will be attended by Oramed,s Chief Scientific Officer, ...
(Date:6/2/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached an agreement to settle ... Delaware Court of Chancery, which names as ... directors and officers, and names the Company as a ... re CytRx Corp. Stockholder Derivative Litigation , C.A. No. ...
(Date:6/2/2015)...  Ashion™ Advanced Individual Medicine™ (AIM), a ... industry, announced today the launch of its ... Medicine Platform. AIM develops and manages comprehensive ... healthcare systems, providing these centers with clinical ... operational support. AIM will use Syapse,s precision ...
Breaking Medicine Technology:Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3
... , NEW YORK , Jan. 25 ... of Kinray announced today a substantial donation to charitable organizations ... the largest privately-held distributor of pharmaceutical, generic, health & beauty ... is listed as #183 according to 2009 Forbes Magazine. , ...
... , PLEASANTON, Calif. ... a world leader in device-based mechanical circulatory support therapies to save, support ... results for the 2009 fiscal year on Thursday, January 28 . ... results and operating activities open to all interested parties at 1:30 ...
Cached Medicine Technology:Pharma Billionaire Stewart Rahr Provides Substantial Donation to Haiti Charities 2Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast 2
(Date:6/2/2015)... Bank, New Jersey (PRWEB) June 02, 2015 ... New Jersey’s largest nonprofit provider of home health ... appointment of its President and CEO, Steve Landers, ... America's (VNAA) Board of Directors. , VNAA ... that supports, promotes and advances mission driven, nonprofit ...
(Date:6/2/2015)... June 02, 2015 TranSlice: Reveal from Pixel ... style. TranSlice: Reveal allows Final Cut Pro X users to ... to reveal their next screen. , TranSlice Reveal brings back ... Final Cut Pro X users can now transition from ... , With every panel orientation and direction covered, no transition ...
(Date:6/2/2015)... Dallas, TX (PRWEB) June 02, 2015 FDA ... to qualified Diet Doc patients after a satisfactory doctor consultation. ... on the market for several years and has the longest ... Working to block the enzyme that breaks down fats in ... diverting them through the intestinal system to be excreted through ...
(Date:6/2/2015)... 2015 Each year, Cosmetic Executive Women ... Awards. This year, the organization’s members – 8,000 industry ... the QVC® Beauty Quest Award at the 2015 Beauty ... (ME) Technology and 2-in-1 approach to skincare differentiated it ... brand’s loyal consumer and professional fan bases, QVC has ...
(Date:6/2/2015)... 02, 2015 Pacifica Graduate Institute ... up by current and former students to honor the ... member from 2002 until his death in 2013. His ... depth of feeling, as well as his passion for ... as an analyst, teacher, and writer were felt in ...
Breaking Medicine News(10 mins):Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 3Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 4Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3
... 2 , , , ... Repurchased shares to be voted in favor of Iridium acquisition , ... , , GHL Acquisition Corp. ("GHL Acquisition") (NYX: ... certain holders of its common stock as a result of which 10,395,763 ...
... Sept. 2 MedQuist Inc. (Nasdaq: MEDQ ) ... revolving credit facility. The credit facility provides committed revolving ... Company may increase its maximum credit up to $40 million, ... is a working capital facility that may be used for ...
... , WASHINGTON, Sept. 2 Denver resident ... to participating in a conspiracy to defraud the Medicare program, Assistant ... Terrence Berg of the Eastern District of Michigan and Daniel R. ... (HHS) announced. , , Vargas-Arias, 46, pleaded ...
... CHADDS FORD, Pa., Sept. 2 Endo Pharmaceuticals (Nasdaq: ... U.S. Food and Drug Administration (FDA) that the agency has extended ... diagnosed with hypogonadism, from Sept. 2, 2009 to Dec. 2, 2009. ... additional data, the agency has informed the company that it needs ...
... , SAN DIEGO, Sept. 2 NuVasive, Inc. ... developing products for minimally disruptive surgical treatments for the spine, announced ... has informed NuVasive of his resignation from his position so that ... Company is currently engaged in a search for a new Chief ...
... getting blood-vessel repairs done, study finds , WEDNESDAY, Sept. ... statin before vascular surgery reduces the risk of complications ... of nearly 500 patients who had surgery for a ... artery blockage and deaths was halved in those who ...
Cached Medicine News:Health News:GHL Acquisition Corp. Announces Share Repurchase Agreements 2Health News:GHL Acquisition Corp. Announces Share Repurchase Agreements 3Health News:MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend 2Health News:Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 2Health News:Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 3Health News:Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 2Health News:Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 3Health News:Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 4Health News:NuVasive Announces Upcoming Departure of Chief Financial Officer 2Health News:NuVasive Announces Upcoming Departure of Chief Financial Officer 3Health News:Statins Before Vascular Surgery Cut Deaths, Complications 2Health News:Statins Before Vascular Surgery Cut Deaths, Complications 3
... are packaged in single-use foil-laminated ... is saturated with precisely the ... package is terminally sterilized, ensuring ... the patient. Swabstick provides excellent ...
... All Povidone Iodine 'Prep' ... skin and mucous membrane ... procedures. All Povidone Iodine ... solutions with surfactants. Each ...
... BETADINE Solution ... of 10% povidone-iodine. It ... antiseptic that kills gram-positive ... antibiotic resistant organisms), as ...
... This multi-purpose topical gel contains 10% Povidone ... germicidal action. As a pre-operative prep, Povidone ... of prepping solutions under the patient, thus ... Gel is also approved as a one ...
Medicine Products: